new glp-1 retatrutide Weight loss drug use requires strict supervision, doctor says Retatrutide's mechanisms of action. |

10.1016/j.brainres.2008.12.025 Brain Res

The peptide has never been tested on humans except for one small trial that was never published

Subsequently, we tested in a randomized clinical trial the efficacy of this blend in sustaining motivated behavior among healthy adults

Due to differences in their pharmacokinetic profiles, in this exploratory experiment, we applied a higher dose of the GLP1/E conjugate (100 nmol/kg), relative to those of the dual (GLP1/GIP) or triple (GLP1/GIP/Glucagon) agonists (10 nmol/kg)

Licensed Peptides supplies 5-Amino-1MQ strictly for investigative and research purposes

All are 100% synthetically manufactured with no animal derivatives